Biomerica Stock Price, News & Analysis (NASDAQ:BMRA)

$3.48 -0.10 (-2.79 %)
(As of 11/20/2017 04:00 PM ET)
Previous Close$3.58
Today's Range$3.40 - $3.51
52-Week Range$1.92 - $3.85
Volume3,273 shs
Average Volume15,162 shs
Market Capitalization$30.5 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.61

About Biomerica (NASDAQ:BMRA)

Biomerica logoBiomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company's diagnostic products use immunoassay technology.


Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:BMRA
  • CUSIP: N/A
  • Web: www.biomerica.com
Debt:
  • Current Ratio: 6.73%
  • Quick Ratio: 3.84%
Sales & Book Value:
  • Annual Sales: $5.79 million
  • Price / Sales: 5.12
  • Book Value: $0.53 per share
  • Price / Book: 6.57
Profitability:
  • Trailing EPS: ($0.12)
  • Net Income: ($900,000.00)
  • Net Margins: -18.19%
  • Return on Equity: -22.82%
  • Return on Assets: -20.22%
Misc:
  • Employees: 39
  • Outstanding Shares: 8,520,000
 

Frequently Asked Questions for Biomerica (NASDAQ:BMRA)

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) posted its earnings results on Monday, October, 16th. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The firm earned $1.44 million during the quarter, compared to the consensus estimate of $1.52 million. Biomerica had a negative net margin of 18.19% and a negative return on equity of 22.82%. View Biomerica's Earnings History.

Who are some of Biomerica's key competitors?

Who are Biomerica's key executives?

Biomerica's management team includes the folowing people:

  • Zackary S. Irani, Chairman of the Board, Chief Executive Officer (Age 51)
  • Francis E. Capitanio, President (Age 73)
  • Janet Moore, Chief Financial Officer, Treasurer, Secretary, Director (Age 66)
  • Allen C. Barbieri, Independent Director (Age 59)
  • Francis R. Cano Ph.D., Independent Director (Age 70)
  • Jane F. Emerson M.D. Ph.D., Independent Director (Age 63)
  • Mark A. Sirgo, Independent Director (Age 64)

How do I buy Biomerica stock?

Shares of Biomerica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biomerica's stock price today?

One share of Biomerica stock can currently be purchased for approximately $3.48.

How big of a company is Biomerica?

Biomerica has a market capitalization of $30.5 million and generates $5.79 million in revenue each year. The company earns ($900,000.00) in net income (profit) each year or ($0.12) on an earnings per share basis. Biomerica employs 39 workers across the globe.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The company can be reached via phone at 949-645-2111.


MarketBeat Community Rating for Biomerica (NASDAQ BMRA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Biomerica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Biomerica (NASDAQ:BMRA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Biomerica (NASDAQ:BMRA)

Price Target History for Biomerica (NASDAQ:BMRA)

Analysts' Ratings History for Biomerica (NASDAQ:BMRA)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for Biomerica (NASDAQ:BMRA)

Earnings by Quarter for Biomerica (NASDAQ:BMRA)

Earnings History by Quarter for Biomerica (NASDAQ BMRA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/16/2017Q1 2018($0.03)($0.02)$1.52 million$1.44 millionViewN/AView Earnings Details
1/17/2017Q2 2017($0.03)($0.02)$1.17 million$1.43 millionViewN/AView Earnings Details
10/15/2015Q1 2016($0.02)($0.01)$1.32 million$1.29 millionViewN/AView Earnings Details
4/15/2015Q3 2015($0.01)($0.02)$1.50 million$1.30 millionViewN/AView Earnings Details
1/15/2015Q2 2015($0.01)($0.03)$1.40 million$1.13 millionViewN/AView Earnings Details
10/16/2014Q1 2015($0.03)($0.03)$1.24 million$1.03 millionViewN/AView Earnings Details
9/2/2014Q4 2014$0.02$0.02$1.43 million$1.68 millionViewN/AView Earnings Details
1/15/2014Nov 2013($0.01)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biomerica (NASDAQ:BMRA)
2018 EPS Consensus Estimate: ($0.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.03)($0.03)($0.03)
Q2 20181($0.03)($0.03)($0.03)
Q3 20181($0.04)($0.04)($0.04)
Q4 20181($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Biomerica (NASDAQ:BMRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Biomerica (NASDAQ BMRA)

Insider Ownership Percentage: 26.30%
Institutional Ownership Percentage: 0.88%
Insider Trades by Quarter for Biomerica (NASDAQ:BMRA)

Insider Trades by Quarter for Biomerica (NASDAQ BMRA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2017Francis E CapitanioPresidentSell15,000$2.46$36,900.00View SEC Filing  
1/4/2017Janet MooreCFOSell4,500$2.20$9,900.00View SEC Filing  
12/22/2016Janet MooreCFOSell9,780$2.18$21,320.40View SEC Filing  
12/12/2016Francis E CapitanioPresidentSell9,351$2.77$25,902.27View SEC Filing  
12/8/2016Francis E CapitanioPresidentSell10,649$2.89$30,775.61View SEC Filing  
11/14/2016Zackary S IraniCEOBuy400$1.94$776.00View SEC Filing  
11/8/2016Zackary S IraniCEOBuy500$1.74$870.00View SEC Filing  
11/4/2016Zackary S IraniCEOBuy1,000$1.95$1,950.00View SEC Filing  
10/20/2016Francis E CapitanioPresidentSell10,000$2.68$26,800.00View SEC Filing  
10/3/2016Jane EmersonDirectorBuy1,000$2.80$2,800.00View SEC Filing  
9/7/2016Zackary S IraniCEOBuy199$2.65$527.35View SEC Filing  
8/12/2016Janet MooreCFOBuy2,200$2.98$6,556.00View SEC Filing  
8/12/2016Zackary S IraniInsiderBuy3,166$2.98$9,434.68View SEC Filing  
8/11/2016Zackary S IraniCEOBuy3,700$2.88$10,656.00View SEC Filing  
8/10/2016Zackary S IraniCEOBuy1,000$2.72$2,720.00View SEC Filing  
8/9/2016Allen BarbieriDirectorBuy3,000$2.54$7,620.00View SEC Filing  
8/5/2016Francis CanoDirectorBuy16,300$2.37$38,631.00View SEC Filing  
8/3/2016Mark A SirgoDirectorBuy4,000$2.05$8,200.00View SEC Filing  
8/3/2016Zackary S IraniCEOBuy2,609$2.10$5,478.90View SEC Filing  
8/2/2016Mark A SirgoDirectorBuy8,000$1.97$15,760.00View SEC Filing  
8/1/2016Zackary S IraniCEOBuy5,400$1.88$10,152.00View SEC Filing  
5/16/2016Francis E CapitanioPresidentSell20,000$1.50$30,000.00View SEC Filing  
11/13/2015Zackary S IraniCEOBuy5,000$0.83$4,150.00View SEC Filing  
6/8/2015Zackary S IraniCEOBuy3,000$1.08$3,240.00View SEC Filing  
5/22/2015Zackary S IraniCEOBuy2,000$0.85$1,700.00View SEC Filing  
5/11/2015Zackary S IraniCEOBuy18,000$0.91$16,380.00View SEC Filing  
9/6/2012Zackary S IraniCEOBuy7,000$0.70$4,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biomerica (NASDAQ BMRA)

Source:

Social Media

Financials

Chart

Biomerica (NASDAQ BMRA) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.